0001127602-23-027226.txt : 20231113 0001127602-23-027226.hdr.sgml : 20231113 20231113161219 ACCESSION NUMBER: 0001127602-23-027226 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231109 FILED AS OF DATE: 20231113 DATE AS OF CHANGE: 20231113 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LaPlume Joseph W CENTRAL INDEX KEY: 0001767215 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15943 FILM NUMBER: 231398825 MAIL ADDRESS: STREET 1: 251 BALLARDVALE STREET CITY: WILMINGTON STATE: MA ZIP: 01887 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CENTRAL INDEX KEY: 0001100682 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 061397316 FISCAL YEAR END: 1230 BUSINESS ADDRESS: STREET 1: 251 BALLARDVALE ST CITY: WILMINGTON STATE: MA ZIP: 01887 BUSINESS PHONE: 781-222-6000 MAIL ADDRESS: STREET 1: 251 BALLARDVALE ST CITY: WILMINGTON STATE: MA ZIP: 01887 FORMER COMPANY: FORMER CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL INC DATE OF NAME CHANGE: 20000605 FORMER COMPANY: FORMER CONFORMED NAME: CHARLES RIVER LABORATORIES HOLDINGS INC DATE OF NAME CHANGE: 19991208 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2023-11-09 0001100682 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL 0001767215 LaPlume Joseph W 251 BALLARDVALE STREET WILMINGTON MA 01887 1 EVP, Corp Strategy & Develop 0 Common Stock 2023-11-09 4 M 0 9128 144.67 A 34111 D Common Stock 2023-11-09 4 S 0 2585 172.77 D 31526 D Common Stock 2023-11-09 4 S 0 6543 173.76 D 24983 D Stock Options (Right to Buy) 144.67 2023-11-09 4 M 0 9128 0 D 2020-02-22 2024-02-22 Common Stock 9128 0 D This transaction was executed in multiple trades at prices ranging from $172.32 to $173.30. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $173.74 to $174.16. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ Joseph W. LaPlume 2023-11-13